메뉴 건너뛰기




Volumn 345, Issue 4, 2006, Pages 1481-1486

Elevated expression of ERK 2 in human tumor cells chronically treated with PD98059

Author keywords

Chronic exposure; ERK 2; MEK inhibitor; Proliferation; Tumor cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SMALL INTERFERING RNA;

EID: 33744516536     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.048     Document Type: Article
Times cited : (7)

References (18)
  • 1
    • 0041926731 scopus 로고    scopus 로고
    • Fidelity and spatio-temporal control in MAP kinase (ERKs) signaling
    • Pouysségur J., and Lenormand P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signaling. Eur. J. Biochem. 270 (2003) 3291-3299
    • (2003) Eur. J. Biochem. , vol.270 , pp. 3291-3299
    • Pouysségur, J.1    Lenormand, P.2
  • 2
  • 3
    • 0013202857 scopus 로고    scopus 로고
    • Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs
    • Kohno M., and Pouysségur J. Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. Prog. Cell Cycle Res. 5 (2003) 219-224
    • (2003) Prog. Cell Cycle Res. , vol.5 , pp. 219-224
    • Kohno, M.1    Pouysségur, J.2
  • 4
    • 10344258041 scopus 로고    scopus 로고
    • Targeting the mitogen-activated protein kinase cascade to treat cancer
    • Sebolt-Leopold J.S., and Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer 4 (2004) 937-947
    • (2004) Nat. Rev. Cancer , vol.4 , pp. 937-947
    • Sebolt-Leopold, J.S.1    Herrera, R.2
  • 7
    • 0141508024 scopus 로고    scopus 로고
    • Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade
    • Collisson E.A., De A., Suzuki H., Gambhir S.S., and Kolodney M.S. Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade. Cancer Res. 63 (2003) 5669-5673
    • (2003) Cancer Res. , vol.63 , pp. 5669-5673
    • Collisson, E.A.1    De, A.2    Suzuki, H.3    Gambhir, S.S.4    Kolodney, M.S.5
  • 10
    • 0035891213 scopus 로고    scopus 로고
    • Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation
    • Nakamura T., Kanda S., Yamamoto K., Kohno T., Maeda K., Matsuyama T., and Kanetake H. Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation. Oncogene 20 (2001) 7610-7623
    • (2001) Oncogene , vol.20 , pp. 7610-7623
    • Nakamura, T.1    Kanda, S.2    Yamamoto, K.3    Kohno, T.4    Maeda, K.5    Matsuyama, T.6    Kanetake, H.7
  • 12
    • 9644257220 scopus 로고    scopus 로고
    • Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response
    • Hii C.S., Anson D.S., Costabile M., Mukaro V., Dunning K., and Ferrante A. Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response. J. Biol. Chem. 279 (2004) 49825-49834
    • (2004) J. Biol. Chem. , vol.279 , pp. 49825-49834
    • Hii, C.S.1    Anson, D.S.2    Costabile, M.3    Mukaro, V.4    Dunning, K.5    Ferrante, A.6
  • 14
    • 0242468891 scopus 로고    scopus 로고
    • CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)
    • Allen L.F., Sebolt-Leopold J., and Meyer M.B. CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK). Semin. Oncol. 30 (2003) 105-116
    • (2003) Semin. Oncol. , vol.30 , pp. 105-116
    • Allen, L.F.1    Sebolt-Leopold, J.2    Meyer, M.B.3
  • 15
    • 0034722894 scopus 로고    scopus 로고
    • Development of anticancer drugs targeting the MAP kinase pathway
    • Sebolt-Leopold J.S. Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 19 (2000) 6594-6599
    • (2000) Oncogene , vol.19 , pp. 6594-6599
    • Sebolt-Leopold, J.S.1
  • 18
    • 1842863982 scopus 로고    scopus 로고
    • Study of MAPK signaling using knockout mice
    • Pagès G., and Pouysségur J. Study of MAPK signaling using knockout mice. Methods Mol. Biol. 250 (2004) 155-166
    • (2004) Methods Mol. Biol. , vol.250 , pp. 155-166
    • Pagès, G.1    Pouysségur, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.